These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21337382)

  • 1. Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolism.
    Ritter CS; Brown AJ
    J Cell Biochem; 2011 May; 112(5):1348-52. PubMed ID: 21337382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
    Ono Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eldecalcitol is less effective in suppressing parathyroid hormone compared to calcitriol in vivo.
    Harada S; Takeda S; Uno A; Takahashi F; Saito H
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):281-3. PubMed ID: 20398764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vitamin D analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) vitamin D(3) (Eldecalcitol) is a potent regulator of calcium and phosphate metabolism.
    Brown AJ; Ritter CS
    Calcif Tissue Int; 2011 Nov; 89(5):372-8. PubMed ID: 21912832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eldecalcitol reduces osteoporotic fractures by unique mechanisms.
    Kondo S; Takano T; Ono Y; Saito H; Matsumoto T
    J Steroid Biochem Mol Biol; 2015 Apr; 148():232-8. PubMed ID: 25625663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current Topics on Vitamin D. Protein interaction and biological action of active vitamin D compounds].
    Ono Y
    Clin Calcium; 2015 Mar; 25(3):387-94. PubMed ID: 25716812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
    Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
    Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo.
    Saito H; Harada S
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():189-96. PubMed ID: 24291401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
    Segersten U; Björklund P; Hellman P; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ; Ritter CS; Knutson JC; Strugnell SA
    Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
    J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the serum vitamin D binding protein in the actions of the vitamin D analog eldecalcitol (ED-71) on bone and mineral metabolism.
    Brown AJ; Zhang F; Cooke NE; Ritter CS
    Calcif Tissue Int; 2013 Aug; 93(2):163-71. PubMed ID: 23689467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
    Saito H; Takeda S; Amizuka N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71].
    Hatakeyama S; Yoshino M; Eto K; Takahashi K; Ishihara J; Ono Y; Saito H; Kubodera N
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):25-8. PubMed ID: 20304058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the vitamin D receptor in regulating vitamin D metabolism: a study of vitamin D-dependent rickets, type II.
    Tiosano D; Weisman Y; Hochberg Z
    J Clin Endocrinol Metab; 2001 May; 86(5):1908-12. PubMed ID: 11344183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
    Magliola L; Anast CS; Forte LR
    Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D3 analogs for the treatment of osteoporosis.
    Hagino H
    Can J Physiol Pharmacol; 2015 May; 93(5):327-32. PubMed ID: 25853632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanisms for the selective action of vitamin D analogs.
    Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    Zierold C; Mings JA; DeLuca HF
    J Cell Biochem; 2003 Feb; 88(2):234-7. PubMed ID: 12520520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.